- Home
- INVA vs BST Comparison
INVA vs BST Comparison
Compare INVA & BST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$21.27
Company Overview
Basic Information| Metric | INVA | BST |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | INVA | BST |
|---|---|---|
| Price | $21.27 | $50.75 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 608.5K | 68.3K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.06% |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 1.25 | N/A |
| Revenue | ★ $217,217,000.00 | N/A |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $12.65 | N/A |
| P/E Ratio | $17.00 | ★ N/A |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $16.52 | $34.87 |
| 52 Week High | $25.15 | $51.30 |
Technical Indicators
Market Signals| Indicator | INVA | BST |
|---|---|---|
| Relative Strength Index (RSI) | 51.23 | 55.20 |
| Support Level | $20.32 | $48.51 |
| Resistance Level | $21.91 | $50.56 |
| Average True Range (ATR) | 0.33 | 0.70 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 56.09 | 49.45 |
Price Performance
Historical Comparison INVA
BST
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objectives are to provide total return and income through long-term capital appreciation.